Holen Sie sich die Stockscreener-App
7.04
7.97%
-0.61
Schlusskurs vom Vortag:
$7.65
Offen:
$7.55
24-Stunden-Volumen:
623.13K
Relative Volume:
0.49
Marktkapitalisierung:
$706.56M
Einnahmen:
$1,000.00K
Nettoeinkommen (Verlust:
$-48.81M
KGV:
-9.0991
EPS:
-0.7737
Netto-Cashflow:
$-39.95M
1W Leistung:
-6.51%
1M Leistung:
+3.23%
6M Leistung:
+79.59%
1J Leistung:
+609.03%
1-Tages-Spanne:
$7.035
$7.59
1-Wochen-Bereich:
$7.035
$8.15
52-Wochen-Spanne:
$0.9714
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
7.04 | 727.63M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
541.69 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
794.19 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,023.21 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.99 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
207.88 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-03-06 | Fortgesetzt | Needham | Buy |
| 2026-01-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Eingeleitet | Wedbush | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Shattuck Labs expects ~$59.4M proceeds from exercised warrants - scanx.trade
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Shattuck (STTK) Results Snapshot: EPS Clears the Reported Estimate in Latest Trading; Reported Share Move: Shares Finish 0.81% Higher in the Latest SessionEarnings Preview - vinanet.vn
Weekly Recap: SL-325 Phase 2b Crohn’s trial and Q2 loss, $208.3M cash - TradingView
Shattuck Labs (NASDAQ:STTK) Cut to Hold at Wall Street Zen - MarketBeat
T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs - Stock Titan
Several Insiders Invested In Shattuck Labs Flagging Positive News - webull.com
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade - Yahoo Finance
A Quick Look at Today's Ratings for Shattuck Labs(STTK.US), With a Forecast Between $11 to $18 - Moomoo
Q3 EPS Estimates for Shattuck Labs Raised by HC Wainwright - MarketBeat
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Shattuck Labs Inc reports results for the quarter ended June 30Earnings Summary - TradingView
H.C. Wainwright cuts Shattuck Labs stock price target on trial expansion - Investing.com
Needham Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Is Shattuck Labs Inc (STTK) Overvalued Following Q2 Earnings Mis - GuruFocus
Shattuck Labs, Inc. Stock 12‑Month Price Target Cut to $14.86, Implies 108% Upside - TradingView
West Tower Group, LLC's Shattuck Labs Inc(STTK) Holding History - GuruFocus
Shattuck Labs, Inc. Stock 12‑Month Price Target Raised to $15.43, Implies 116% Upside - TradingView
STTK Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
HC Wainwright Cuts Shattuck Labs (NASDAQ:STTK) Price Target to $14.00 - MarketBeat
Shattuck Labs Raises Cash Reserves to $208.3 Million, Extending Runway to 2029 - Minichart
Shattuck Labs (NASDAQ:STTK) Releases Earnings Results, Hits Expectations - MarketBeat
Shattuck Labs Releases Q2 2026 10-Q Filing Highlighting Key Risk Factors and Share Count - Kalkine Media
Shattuck Labs Q2 Results: EPS misses estimate, losses widen 50% YoY - scanx.trade
Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases - Bitget
Form 8K Shattuck Labs Inc For: 11 August By Investing.com - Investing.com South Africa
Why is Shattuck Labs stock slipping today? By Investing.com - Investing.com Canada
STTK Looks 580.0% Overvalued on GF Value™ - GuruFocus
Shattuck Labs Reports $15.2 Million Q2 Loss and 2029 Cash Runway - Quiver Quantitative
Shattuck Labs Q2 FY26 net loss widens to $15.2 million; R&D expenses rise to $11.7 million - Bitget
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Reports Positive Phase 1 Data for SL-325 and Advances DR3 Pipeline with Phase 2b Crohn’s Study Planned for 2026 - Quiver Quantitative
Shattuck Labs 2Q Loss $15.2M >STTK - Moomoo
Shattuck Labs Inc (STTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certain Pre-Funded Warrants of Shattuck Labs, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.com
Certain Common Stock of Shattuck Labs, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.com
Shattuck Labs, Inc. $STTK Stock Holdings Lifted by Renaissance Technologies LLC - MarketBeat
Shattuck Labs Inc (STTK) Stock News Today - TradingKey
STTK Q1 2026 Earnings: Smaller-Than-Expected Loss Offers a Cautious Bright SpotEarnings Growth Forecast - Vinanet
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Shattuck Labs (STTK) Projected to Release Earnings on Thursday - marketbeat.com
Shattuck Labs (STTK) Slips 4.4% to $7.58 as Biotech Volatility PersistsLarge Cap Trends - dars.gov.et
STTK Q2'26 Earnings: EPS estimate is (0.12) USD - TradingView
Shattuck Labs (STTK) Slips 1.67% as Shares Test Support Near $6.72Volatility Surface - vinanet.vn
Shattuck Labs (STTK) Q1 2026 Earnings: Narrower Loss of $0.13 Per Share Beats Estimates as Clinical Pipeline Takes Center StageOperating Margin Analysis - dars.gov.et
STTK Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Shares HigherEstimate Uncertainty - vinanet.vn
STTK Q2'26 Earnings: revenue estimate is 0 USD - TradingView
STTK|Shattuck Labs Inc|Price:7.070|Chg%:-0.120 - tradingkey.com
Shattuck Labs Inc (STTK) Institutional Confidence - TradingKey
Shattuck Labs Inc (STTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STTK|Shattuck Labs Inc|Price:7.430|Chg%:+0.340 - TradingKey
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Shattuck Labs Inc-Aktie (STTK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Option Exercise |
3.57 |
410 |
1,464 |
86,790 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 02 '26 |
Sale |
7.01 |
410 |
2,874 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Option Exercise |
3.57 |
23,365 |
83,413 |
109,745 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Option Exercise |
3.57 |
100 |
357 |
86,480 |
| Shukla Abhinav A. | Chief Technical Officer |
Jun 30 '26 |
Sale |
7.08 |
23,365 |
165,424 |
86,380 |
| Shukla Abhinav A. | Chief Technical Officer |
Jul 01 '26 |
Sale |
7.07 |
100 |
707 |
86,380 |
| Pandite Arundathy N. | Chief Medical Officer |
Jun 30 '26 |
Sale |
7.01 |
30,000 |
210,300 |
136,219 |
8.37%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):